DK1561460T3 - Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme - Google Patents

Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme

Info

Publication number
DK1561460T3
DK1561460T3 DK03765124T DK03765124T DK1561460T3 DK 1561460 T3 DK1561460 T3 DK 1561460T3 DK 03765124 T DK03765124 T DK 03765124T DK 03765124 T DK03765124 T DK 03765124T DK 1561460 T3 DK1561460 T3 DK 1561460T3
Authority
DK
Denmark
Prior art keywords
nanoparticles
active ingredients
administration
preparing
particles
Prior art date
Application number
DK03765124T
Other languages
Danish (da)
English (en)
Inventor
Fernandez Maria Jose Alonso
Lopez Carmen Remunan
Vilan Margarita Maria Cuna
Sande Maria Alonso
Jato Jose Luis Vila
Original Assignee
Advancell Advanced In Vitro Ce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advancell Advanced In Vitro Ce filed Critical Advancell Advanced In Vitro Ce
Application granted granted Critical
Publication of DK1561460T3 publication Critical patent/DK1561460T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03765124T 2002-07-19 2003-07-16 Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme DK1561460T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200201694A ES2221530B1 (es) 2002-07-19 2002-07-19 Nanoparticulas para la administracion de ingredientes activos,procedimiento para la elaboracion de dichas particulas y composicion que las contienen.
PCT/ES2003/000372 WO2004009060A1 (fr) 2002-07-19 2003-07-16 Nanoparticules pour l'administration de principes actifs, procede d'elaboration desdites particules et composition les contenant

Publications (1)

Publication Number Publication Date
DK1561460T3 true DK1561460T3 (da) 2007-04-30

Family

ID=30470576

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03765124T DK1561460T3 (da) 2002-07-19 2003-07-16 Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme

Country Status (11)

Country Link
US (1) US20060134785A1 (fr)
EP (1) EP1561460B1 (fr)
AT (1) ATE348602T1 (fr)
CA (1) CA2492995A1 (fr)
CY (1) CY1106361T1 (fr)
DE (1) DE60310605T2 (fr)
DK (1) DK1561460T3 (fr)
ES (2) ES2221530B1 (fr)
PT (1) PT1561460E (fr)
SI (1) SI1561460T1 (fr)
WO (1) WO2004009060A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
US20080241260A1 (en) * 2005-09-28 2008-10-02 Padma Venkitachalam Devarajan Compositions for Enhanced Absorption of Biologically Active Agents
EP1774971A1 (fr) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Nanoparticules comprenant de chitosane et d'héparine
US20110135742A1 (en) * 2006-06-20 2011-06-09 The Regents Of The University Of California Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles
US9173852B2 (en) * 2008-04-08 2015-11-03 Tian Si Polymer Materials Technology Development Co. Glycyrrhetinic acid-mediated nanoparticles of hepatic targeted drug delivery system, process for preparing the same and use thereof
JP5804453B2 (ja) * 2009-05-14 2015-11-04 国立大学法人 東京大学 結晶性ポリオール微粒子及びその調製方法
CA2767443A1 (fr) * 2009-07-09 2011-01-13 Polymers Crc Limited Systeme d'administration de depot de gel hybride de biopolymere
DE102009048553A1 (de) 2009-09-29 2011-03-31 Carl Zeiss Smt Gmbh Katadioptrisches Projektionsobjektiv mit Umlenkspiegeln und Projektionsbelichtungsverfahren
US8802076B2 (en) 2010-10-04 2014-08-12 Duke University Compositions and methods for modulating an immune response
JP5903250B2 (ja) * 2011-11-16 2016-04-13 清水化学株式会社 徐放性組成物
KR101372834B1 (ko) * 2011-12-12 2014-03-14 전북대학교산학협력단 하이드로겔 버블 및 이의 제조방법
US9114091B2 (en) * 2013-07-05 2015-08-25 Shimizu Chemical Corporation Sustained release solid dosage preparations
CN107970228A (zh) * 2017-11-02 2018-05-01 天津大学 一种以壳聚糖-tpp-kgm为复合壁材的纳米微囊的制备方法
CN111420067B (zh) * 2020-03-09 2021-08-27 西南交通大学 一种复合微球纳米载体及其制备方法和应用
WO2021209493A2 (fr) * 2020-04-15 2021-10-21 Solyplus Gmbh Moyens et procédés de prévention et de traitement d'infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688422A1 (fr) * 1992-03-11 1993-09-17 Coletica Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant.
ES2114502B1 (es) * 1996-07-29 1999-07-01 Univ Santiago Compostela Aplicacion de nanoparticulas a base de polimeros hidrofilicos como formas farmaceuticas.

Also Published As

Publication number Publication date
DE60310605T2 (de) 2007-09-27
ES2221530A1 (es) 2004-12-16
EP1561460B1 (fr) 2006-12-20
SI1561460T1 (sl) 2007-06-30
CY1106361T1 (el) 2011-10-12
US20060134785A1 (en) 2006-06-22
ES2221530B1 (es) 2006-02-16
WO2004009060A1 (fr) 2004-01-29
CA2492995A1 (fr) 2004-01-29
ES2279172T3 (es) 2007-08-16
PT1561460E (pt) 2007-03-30
EP1561460A1 (fr) 2005-08-10
DE60310605D1 (de) 2007-02-01
ATE348602T1 (de) 2007-01-15

Similar Documents

Publication Publication Date Title
DK1561460T3 (da) Nanopartikler til indgivelse af aktive ingredienser, fremgangsmåde til fremstilling af nævnte partikler og komposition, som omfatter det samme
CA2481848A1 (fr) Particules d'ingredients actifs comprenant du clopidogrel ou un sel, leurs utilisations et procede de preparation
MY143795A (en) Tetrahydropyridoindole derivatives
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
TW200637581A (en) Anti-caries oral care composition with a chelating agent
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ATE546135T1 (de) Hyaluronsäure-nanopartikel
CA2468916A1 (fr) Formulations pharmaceutiques renfermant un derive du platine
DK1401501T3 (da) Orale farmaceutiske sammensætninger med modificeret frigivelse af den aktive ingrediens
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
WO2004078105A3 (fr) Composition de fondaparinux sodique de haute purete
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
BG108516A (en) Pharmaceutical formulation
FI20011703A7 (fi) Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
AU2001274374A1 (en) Matrix protein compositions for dentin regeneration
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
JP7146388B2 (ja) 口腔用組成物製造方法
WO1999047172A3 (fr) Compositions pharmaceutiques orales a prendre sans liquides et contenant des composes d'inclusion
AU2003224107A1 (en) Soluble composition containing sporopollenin and the use thereof
DE60004204D1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung
ATE404192T1 (de) Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
DE60319983D1 (de) Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine